Pitching sessions
Global Innovation Showcase: Startups from the Global Village
Pitching session summary
Explore cutting-edge biotech startups from around the world, developing innovative products and technologies to address global health challenges. Join us to discover the future of biotech, hear from visionary founders, and uncover exciting investment opportunities.
Date, time and room information
Global Village track: May 5, 16:45-17:45, room Verseau
Moderation
| Name | Position | Institution |
|---|---|---|
| Maximilien Murone | Swiss Biotech Association |
Pitching companies
| Company name | Pitcher | Title of presentation | Link to company website |
|---|---|---|---|
| Delegation of Oregon; Araceli Biosciences | Shawn MacDonald, CFO | Speeding the Science That Saves Lives | https://www.aracelibio.com/ |
| Delegation of Belgium; Amyl Therapeutics | Pierre Vandepapeliere, CEO | A breakthrough therapy for Alzheimer’s disease | https://www.amyltx.com/ |
| Delegation of Belgium; DeuterOncology | Carol Walton, BD & Strategy Advisor | DO-2: Next generation MET inhibitor | https://deuteroncology.com/ |
| Delegation of the Nordic countries; Mavatar | Johan Julin, CEO | Delivering Precision | https://www.mavatar.com/ |
| Delegation of Czechia; Adalid Sciences | Klara Grantz Sasková, Co-Founder & CEO | Novel Lipid Nanoparticles for effective Gene Delivery | https://www.adalidsciences.com/ |
| Delegation of Italy; Softmining Srl | Stefano Piotto, CEO | Advanced Algorithms for Life Sciences | https://www.softmining.it/ |
| Delegation of Canada; Tatum Bioscience | Jean-Francois Millau, CEO | Unleashing Complete Antitumor Response | https://www.tatumbio.com/ |
| Delegation of South Korea; ILIAS Biologics, Inc. | Chulhee Choi, CEO/CSO | The Global Leader in Exosome Therapeutics - Relentless Innovators | https://www.iliasbio.com/ |
| Delegation of Bavaria; T-CURX - Frontline Cancer Immunotherapy | Ulf Grawunder, CEO | Democratizing CAR-T Cell Therapies for Patients Globally | https://www.t-curx.com/ |
Jury members
| Name | Position | Institution |
|---|---|---|
| Zoë Johnson | CSO | Molecule to Medicine |
| Frederic Levy | CSO | Debiopharm |
| Kostas Kaloulis | Partner | ND Capital |
| Veronica Gambillara | Partner | Pureos Bioventures |
| Nikita Sharma | Principal | Versant Ventures |
| Daniela Couto | Partner | BioGeneration Ventures (BGV) |
